D Alarcón-Segovia. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, AntinuclearAnticonvulsants/adverse effectsHumansHydralazine/adverse effectsIsoniazid/adverse effectsLupus Erythematosus, Systemic/chemically inducedLupus Erythematosus, Systemic/etiologyLupus Erythematosus, Systemic/geneticsProcainamide/adverse effects
Substances: See more » Antibodies, AntinuclearAnticonvulsantsHydralazineProcainamideIsoniazid
Year: 1969 PMID: 4898319
Source DB: PubMed Journal: Mayo Clin Proc ISSN: 0025-6196 Impact factor: 7.616